Inhibition of melanogenesis by HLA class II molecules

Noriko Arase,Atsushi Tanemura,You Reiri,Megumi Nishioka,Hui Jin,Hisashi Arase,Ichiro Katayama
DOI: https://doi.org/10.1016/j.jdermsci.2016.08.266
IF: 5.408
2016-01-01
Journal of Dermatological Science
Abstract:HLA class II molecules usually presents peptide antigens derived from extracellular proteins to CD4+T cells. We recently found that HLA class II molecules associate with not only peptide antigens but also endogenous proteins. HLA class II molecules preferentially associated with misfolded proteins and transported them to the cell surface without processing to peptides. Furthermore, misfold proteins complexed with HLA class II molecules are specifically recognized by autoantibodies produced in rheumatoid arthritis. In the present study, we found that HLA class II molecules also associate with tyrosinase and inhibit melanin synthesis induced by tyrosinase. Efficiency to inhibit melanin synthesis of tyrosinase by HLA class II molecules was different depending on the alleles of HLA class II molecules. Furthermore, Rododenol augmented inhibition of melanin synthesis by HLA class II molecules by 50%. Because IFN-γ strongly induces HLA-Class II expression in the melanocytes and dermatitis frequently precedes chemically induced vitiligo or vitiligo vulgaris, inhibition of melanogenesis by HLA class II molecules induced by dermatitis might be involved pathogenesis of acquired vitiligo in some cases.
What problem does this paper attempt to address?